News | March 24, 2008

Cardiac Patient Tracked from Door-to-Cath Lab at SCAI, ACC Conference

March 25, 2008 - Medical Simulation Corp. will present a comprehensive onset-of-symptoms-to-cath lab scenario at the SCAI/ACC national conference in Chicago, IL, March 30-April 1, in a presentation that follows a patient suffering from myocardial infarction from door-to-cath lab.

The presentation, which takes place on Monday, March 31 at 1:30 p.m. in the Simulation Pavilion 360 Degree Theater, is said to represent a milestone in simulation education, as multiple simulators are incorporated to deliver a comprehensive training experience. The simulated scenario will follow a patient suffering from an acute myocardial infarction (AMI) from the onset of symptoms and through the EMS and ER process of care using a human patient simulator. The patient will then be transferred to the cath lab for a cardiovascular intervention using MSC’s endovascular simulator.

“By incorporating the complete process of care, this scenario will highlight the complexities surrounding the treatment of a cardiac patient from the onset of symptoms to the cath lab,” said Mark A. Turco, M.D., FACC, FSCAI, director of the Center for Cardiac & Vascular Research at Washington Adventist Hospital in Takoma Park, MD. “A primary initiative in improving care of AMI patients is finding ways to speed the door-to-cath lab time with the overall goal of saving more heart muscle. Simulation training provides the ideal platform to address these challenges in a realistic environment.”

“MSC is proud to continue to deliver more advanced simulation training opportunities to healthcare providers,” said Bill Younkes, MSC president. "As we move closer to simulating the entire process of care, education empowered by simulation can have a greater impact on improving patient outcomes and safety."

For more information: www.medsimulation.com

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init